300630 普利製藥
按盤價 
6.960 -0.020 (-0.287%)
6.960 -0.020 (-0.287%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -3.439 | 3.141 | 11.553 | 18.189 | 25.585 |
| 總資產報酬率 ROA (%) | -1.567 | 1.386 | 5.473 | 10.795 | 17.061 |
| 投入資產回報率 ROIC (%) | -1.709 | 1.572 | 6.276 | 12.365 | 19.877 | 邊際利潤分析 |
| 銷售毛利率 (%) | 59.826 | 73.054 | 65.168 | 71.577 | 74.758 |
| 營業利潤率 (%) | -19.985 | 3.671 | 17.852 | 31.024 | 38.516 |
| 息稅前利潤/營業總收入 (%) | -15.149 | 9.363 | 19.788 | 33.950 | 39.293 |
| 淨利潤/營業總收入 (%) | -15.717 | 6.587 | 18.217 | 27.611 | 34.280 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 137.716 | 5.084 | 100.533 | 101.202 | 96.547 |
| 價值變動淨收益/利潤總額(%) | -5.535 | 5.884 | -0.519 | -0.759 | 0.063 |
| 營業外收支淨額/利潤總額(%) | 9.091 | 35.998 | -0.203 | -0.118 | -0.784 | 償債能力分析 |
| 流動比率 (X) | 1.565 | 1.382 | 1.378 | 1.948 | 1.828 |
| 速動比率 (X) | 1.178 | 1.164 | 1.202 | 1.696 | 1.688 |
| 資產負債率 (%) | 55.089 | 53.772 | 58.067 | 45.482 | 0.333 |
| 帶息債務/全部投入資本 (%) | 48.648 | 45.121 | 47.551 | 34.903 | 15.772 |
| 股東權益/帶息債務 (%) | 99.069 | 113.499 | 102.593 | 175.795 | 498.001 |
| 股東權益/負債合計 (%) | 81.525 | 85.971 | 72.214 | 119.867 | 200.536 |
| 利息保障倍數 (X) | -2.217 | 2.581 | 10.031 | 11.457 | 36.521 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 494.868 | 311.180 | 214.963 | 175.854 | 140.733 |
| 存貨周轉天數 (天) | 481.747 | 353.017 | 189.105 | 149.531 | 98.272 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 26/12/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
